Try our Advanced Search for more refined results

March 30, 2020

HANN v. HERITAGE PHARMACEUTICALS, INC.

Track this case

Case Number:

3:20-cv-03415

Court:

New Jersey

Nature of Suit:

Other Fraud

Multi Party Litigation:

Class Action

Judge:

Brian R. Martinotti

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 31, 2020

    Avet Diabetes Med Contains Carcinogen, Suit Says

    Heritage Pharmaceuticals Inc. is making and selling a generic blood sugar control medication for diabetes patients that contains "dangerously high levels" of an impurity that can cause cancer and liver damage, according to a proposed class action filed in New Jersey federal court.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login